Figure 2

Kaplan-Meier survival analysis by CD133, CD44, MVD, and CD82 statuses. (A) Kaplan-Meier survival analysis by CD133 status (n = 325). Mean overall survival (OS) time was 46.8 months for the CD133-positive group and 57.9 months for the CD133-negative group (log rank = 16.243, P < 0.001). (B) Kaplan-Meier survival analysis by CD44 status (n = 325). Mean OS time was 48.7 months for the CD44-positive group and 57.0 months for the CD44-negative group (log rank = 5.340, P = 0.021). (C) Kaplan-Meier survival analysis by MVD status (n = 325). Mean OS time was 48.4 months for the MVD ≥21 group and 57.0 months for the MVD <21 group (log rank = 9.623, P = 0.002). (D) Kaplan-Meier survival analysis by CD82 status (n = 325). Mean OS time was 60.8 months for the CD82-positive group and 46.5 months for the CD82-negative group (log rank = 23.644, P < 0.001).